DIVINCI: Dissection of Influenza Vaccination and Infection for Childhood Immunity
DIVINCI:剖析流感疫苗和感染对儿童免疫的影响
基本信息
- 批准号:10614457
- 负责人:
- 金额:$ 486.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-05-02 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectAntibodiesAntibody ResponseAntigensB-LymphocytesBiological AssayBirthBlood BanksBlood specimenCD8-Positive T-LymphocytesCD8B1 geneCellsCellular AssayChildChildhoodChronologyClinicalCohort StudiesCollaborationsDevelopmentDiseaseDisparateDissectionElderlyEnrollmentEnsureEpigenetic ProcessExposure toHeadHemagglutininHumanImmuneImmune responseImmune systemImmunityImmunologic MemoryImmunologicsIndividualInfantInfectionInfluenzaInfluenza vaccinationInvestigationJointsLifeLongevityLongitudinal cohortLos AngelesMediatingMemoryMethodsNeuraminidaseNew ZealandNewborn InfantNicaraguaNicaraguanPost-Translational Protein ProcessingPredispositionProductivityPublic HealthPublicationsRecording of previous eventsRecoveryResearchResearch PersonnelSamplingSeasonsSerologySiteSpecificityT cell responseT-Cell Immunologic SpecificityT-LymphocyteTestingVaccinatedVaccinationVaccinesVirusanti-influenzacohortdemographicsdesignexperienceflu transmissionimprintimprovedinfluenza infectioninfluenza virus vaccineinfluenzavirusinnovationinsightmembernovelnovel vaccinesprogramsreceptorrecruitresponseunvaccinatedvaccine effectivenessvaccine strategyvaccine-induced antibodies
项目摘要
SUMMARY
Globally, influenza virus is a major public health burden. Evidence suggests that an individual’s earliest
exposures to influenza have profound effects on immunity against the virus throughout life. Well-curated, infant
cohorts, used to interrogate the full spectrum of immune responses against early influenza exposures, and
examined for subsequent exposures have been lacking. Our premise of this proposal is that the antigenic form
(strain, infection vs. vaccination) of an encounter with influenza virus results in disparate immunological memory
profiles, particularly in B and T cell repertoires. Specifically, we will examine how influenza infection- and
vaccination-mediated imprinting modulates the breadth, longevity, and functional quality of B cell and antibody
responses and dictates the specificity, receptor profiles, functional activity and epigenetic state of the T cell
responses to subsequent influenza exposures. In addition, we will examine how these parameters are impacted
by repeated exposure to influenza. We will address these questions by comprehensively assessing the B and T
cell immune responses induced by influenza infection and vaccination in three unique birth cohort studies: 1)
Managua, Nicaragua; 2) Wellington, New Zealand; and 3) Los Angeles, CA. Through the three sites, chosen
because of our extensive experience with conduct of cohort studies and enrollment of infants, distinct seasonal
transmission of influenza, and diverse demographics, we will establish a cohort of ~3,100 children, with 2,100
newborns enrolled over the course of the U01 and an additional ~1,000 children who have already been followed
since birth for up to 8 years for symptomatic influenza infection and have existing banked blood samples. Our
central hypothesis is that the chronology of initial and subsequent influenza exposures has long lasting
effects on anti-influenza responses (“imprinting”), setting infants on diverse immunological trajectories
mediated by the recruitment of distinct B and T cell specificities and functional capabilities. We will test
this hypothesis through establishment of the cohort (Aim 1), examining the response to initial exposures (Aim 2),
examining the response to subsequent exposures (Aim 3) and evaluating correlates of protection (Aim 4). We
have formed a Consortium of world-renowned investigators who have a long history of collaboration (>150
publications). Combining extensive experience and on-going programs in clinical, immunological, and virological
research ensures a high-quality, successful research program. This U01 will result in: 1) New insight on the
mechanisms of imprinting; 2) Improved understanding of what constitutes protective immunity in early and
subsequent influenza infections, including the effects of vaccination; and 3) Identification of natural and vaccine-
induced B cell/antibody and CD4+/CD8+ T cell correlates of protection. These investigations provide a novel
opportunity to combine unique cohorts with exhaustive immune profiling, generating critical insights for new
vaccine strategies to induce broadly protective immunity to influenza virus.
概括
在全球范围内,流感病毒是一个主要的公共卫生负担。
接触流感对婴儿一生对病毒的免疫力产生深远影响。
队列,用于询问针对早期流感暴露的全方位免疫反应,以及
我们提出这一建议的前提是缺乏抗原形式。
接触流感病毒(毒株、感染与疫苗接种)会导致不同的免疫记忆
具体而言,我们将研究流感病毒感染和传播的方式。
疫苗介导的印记调节 B 细胞和抗体的宽度、寿命和功能质量
反应并决定 T 细胞的特异性、受体谱、功能活性和表观遗传状态
此外,我们将研究这些参数是如何受到影响的。
我们将通过全面评估 B 和 T 来解决这些问题。
三项独特的出生队列研究中流感感染和疫苗接种诱导的细胞免疫反应:1)
尼加拉瓜马那瓜;2) 新西兰惠灵顿;以及 3) 加利福尼亚州洛杉矶 通过这三个地点。
由于我们在进行队列研究和婴儿入组方面拥有丰富的经验,因此不同的季节性
由于流感传播和不同的人口统计数据,我们将建立一个由约 3,100 名儿童组成的队列,其中 2,100
在 U01 课程中登记的新生儿以及另外约 1,000 名已接受跟踪的儿童
自出生起长达 8 年内有症状的流感感染并且已有储存的血液样本。
中心假设是,最初和随后的流感暴露的时间顺序是长期持续的
对抗流感反应(“印记”)的影响,使婴儿处于不同的免疫轨迹
我们将测试通过招募不同的 B 细胞和 T 细胞特异性和功能能力来介导。
通过建立队列(目标 1)、检查对初始暴露的反应(目标 2)来实现这一假设,
检查对后续暴露的反应(目标 3)并评估保护的相关性(目标 4)。
已经成立了一个由世界知名的研究人员组成的联盟,这些研究人员有着悠久的合作历史(> 150
出版物)结合了临床、免疫学和病毒学方面的丰富经验和正在进行的项目。
研究确保了高质量、成功的研究计划。该 U01 将带来: 1) 对以下问题的新见解。
2) 更好地理解早期和晚期保护性免疫的构成;
随后的流感感染,包括疫苗接种的影响;以及 3) 天然和疫苗的鉴定
诱导 B 细胞/抗体和 CD4+/CD8+ T 细胞的保护相关性这些研究提供了一种新颖的方法。
有机会将独特的队列与详尽的免疫分析相结合,为新的研究产生重要的见解
诱导对流感病毒的广泛保护性免疫力的疫苗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AUBREE L GORDON其他文献
AUBREE L GORDON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AUBREE L GORDON', 18)}}的其他基金
Household Respiratory Virus SARS-CoV-2 Transmission and Immunity Sub-Study (HRTS)
家庭呼吸道病毒 SARS-CoV-2 传播和免疫子研究 (HRTS)
- 批准号:
10265686 - 财政年份:2020
- 资助金额:
$ 486.23万 - 项目类别:
DIVINCI: Dissection of Influenza Vaccination and Infection for Childhood Immunity
DIVINCI:剖析流感疫苗和感染对儿童免疫的影响
- 批准号:
10400037 - 财政年份:2019
- 资助金额:
$ 486.23万 - 项目类别:
DIVINCI: Dissection of Influenza Vaccination and Infection for Childhood Immunity
DIVINCI:剖析流感疫苗和感染对儿童免疫的影响
- 批准号:
9924481 - 财政年份:2019
- 资助金额:
$ 486.23万 - 项目类别:
DIVINCI: Dissection of Influenza Vaccination and Infection for Childhood Immunity
DIVINCI:剖析流感疫苗和感染对儿童免疫的影响
- 批准号:
10153694 - 财政年份:2019
- 资助金额:
$ 486.23万 - 项目类别:
Dynamics of Influenza Transmission in Nicaraguan Households
尼加拉瓜家庭流感传播动态
- 批准号:
9234280 - 财政年份:2017
- 资助金额:
$ 486.23万 - 项目类别:
Dynamics of Influenza Transmission in Nicaraguan Households
尼加拉瓜家庭流感传播动态
- 批准号:
10078840 - 财政年份:2017
- 资助金额:
$ 486.23万 - 项目类别:
Development of Adaptive Immunity to Influenza A: A Longitudinal Study of Anti-Hemagglutinin Antibodies, Their Cross-Reactivity and Protection in Children
甲型流感适应性免疫的发展:抗血凝素抗体、其交叉反应性和儿童保护的纵向研究
- 批准号:
9014901 - 财政年份:2016
- 资助金额:
$ 486.23万 - 项目类别:
相似国自然基金
P29单克隆抗体的3-羟基丁酰化修饰对其稳定性影响及提升抗泡型包虫病作用的研究
- 批准号:82360402
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
SARS-CoV-2 S2蛋白与肠道菌群交叉反应抗体的产生机制及其对新冠肺炎病程和疫苗效果的影响
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
肠道菌群影响PD-1抗体对潜伏HIV的作用及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
模式识别受体通过调节脂质代谢影响中性粒细胞程序性死亡参与抗中性粒细胞胞浆抗体相关小血管炎发病机制的研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
相似海外基金
Designing Rational Combinations to Improve CAR T Cell Therapy for Prostate Cancer
设计合理的组合以改善前列腺癌的 CAR T 细胞疗法
- 批准号:
10752046 - 财政年份:2024
- 资助金额:
$ 486.23万 - 项目类别:
Growth plate-targeted IGF1 to treat Turner Syndrome
生长板靶向 IGF1 治疗特纳综合征
- 批准号:
10819340 - 财政年份:2023
- 资助金额:
$ 486.23万 - 项目类别:
A First-in-class Topical Immunoregulatory Therapeutic for Psoriasis
一流的牛皮癣局部免疫调节疗法
- 批准号:
10820331 - 财政年份:2023
- 资助金额:
$ 486.23万 - 项目类别:
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
传染病、自身免疫和 B 细胞癌症背景下的 B 细胞生物学
- 批准号:
10683443 - 财政年份:2023
- 资助金额:
$ 486.23万 - 项目类别:
Incidence and Time on Onset of Cardiovascular Risk Factors and Cardiovascular Disease in Adult Survivors of Adolescent and Young Adult Cancer and Association with Exercise
青少年和青年癌症成年幸存者心血管危险因素和心血管疾病的发病率和时间以及与运动的关系
- 批准号:
10678157 - 财政年份:2023
- 资助金额:
$ 486.23万 - 项目类别: